---
id: ITE-2024-093
type: ITE
year: 2024
number: 93
created: 2025-08-10 13:35:41.395633
tags:
- ITE
- question
- ITE-2024
- 2024-exam
answer: C
topic: Infectious Disease
related_articles:
- title: PubMed Entry
  path: 2022/2022-12-when-antibiotics-can-help-with-upper-respiratory-infections.md
  similarity: 0.4
  link: '[[2022-12-when-antibiotics-can-help-with-upper-respiratory-infections|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-09-comparable-outcomes-with-five-and-10-days-of-antibiotics-in.md
  similarity: 0.4
  link: '[[2022-09-comparable-outcomes-with-five-and-10-days-of-antibiotics-in|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-11-binx-io-point-of-care-test-for-chlamydia-trachomatis-and-nei.md
  similarity: 0.2
  link: '[[2022-11-binx-io-point-of-care-test-for-chlamydia-trachomatis-and-nei|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c.md
  similarity: 0.2
  link: '[[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice.md
  similarity: 0.2
  link: '[[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]]'
topics:
- Infectious Disease
- Pediatrics
related_articles_2023_2025:
- title: afp clinical answers
  path: 2024/10/2024-10-afp-clinical-answers.md
  similarity: 0.406
  link: '[[2024/10/2024-10-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2023/07/2023-07-afp-clinical-answers.md
  similarity: 0.404
  link: '[[2023/07/2023-07-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2024/08/2024-08-afp-clinical-answers.md
  similarity: 0.403
  link: '[[2024/08/2024-08-afp-clinical-answers|afp clinical answers]]'
- title: fatigue adults
  path: 2023/07/2023-07-fatigue-adults.md
  similarity: 0.313
  link: '[[2023/07/2023-07-fatigue-adults|fatigue adults]]'
- title: practice guidelines headache pregnancy ureastfeeding
  path: 2023/07/2023-07-practice-guidelines-headache-pregnancy-breastfeeding.md
  similarity: 0.312
  link: '[[2023/07/2023-07-practice-guidelines-headache-pregnancy-breastfeeding|practice
    guidelines headache pregnancy ureastfeeding]]'
last_updated: '2025-08-10T20:27:11.095055'
---

# Question ITE-2024-093

## Question
A 23 -month -old toddler is brought to the clinic with a temperature of 38.2 °C (100.7 °F). The parents 
say the child has been urinating more frequently. A urine dipstick and culture confirm a urinary tract infection.  
 
After treatment with an antibiotic, whi ch one of the following would be the most appropriate next 
step?

## Answer Choices
**A)** A repeat urine culture
**B)** Antibiotic prophylaxis
**C)** Renal and bladder ultrasonography
**D)** A voiding cystourethrogram
**E)** A dimercaptosuccinic acid (DMS

## Correct Answer
**C**

## Explanation
The American Academy of Pediatrics recommends renal and bladder ultrasonography in children ≤24 months of age after a first episode of febrile urinary tract infection (UTI) to assess for vesicoureteral reflux. A voiding cystourethrogram is indicated if the re are abnormal findings on ultrasonography. A repeat urine culture and prophylactic antibiotic therapy are not indicated in this case. Most children do not need a dimercaptosuccinic acid (DMSA) renal scan after a first episode of UTI.

## References
s Mattoo TK, Shaikh N, Nelson CP. Contemporary management of urinary tract infection in children. Pediatrics . 2021;147(2):e2020012138. Veauthier B, Miller MV. Urinary tract infections in young children and infants: common questions and answers. Am Fam Physician . 2020;102(5):278 -285.

## Related AAFP Articles
- [[2022-12-when-antibiotics-can-help-with-upper-respiratory-infections|PubMed Entry]] (Relevance: 40%)
- [[2022-09-comparable-outcomes-with-five-and-10-days-of-antibiotics-in|PubMed Entry]] (Relevance: 40%)
- [[2022-11-binx-io-point-of-care-test-for-chlamydia-trachomatis-and-nei|PubMed Entry]] (Relevance: 20%)
- [[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed Entry]] (Relevance: 20%)
- [[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]] (Relevance: 20%)

---
*Source: 2024 ABFM In-Training Examination*